-
Applied UV Announces Closing of $6.4 Million Upsized Underwritten Public Offering
[ad_1] MOUNT VERNON, NY – (NewMediaWire) – November 16, 2023 – Applied UV, Inc. (Nasdaq: AUVI; AUVIP) (“Applied UV” or…
Read More » -
CGrowth Capital Secures $1 Million in Non-Debt Financing
[ad_1] NEW YORK, NY – (NewMediaWire) – November 16, 2023 – CGrowth Capital Inc. (OTC: CGRA) is a public holding…
Read More » -
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
[ad_1] FREMONT, CA – (NewMediaWire) – November 16, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing therapeutic…
Read More » -
US Nuclear Advances Fight Against Opioid Crisis With Breakthrough Fentanyl Detection Technology
[ad_1] LOS ANGELES, CA – (NewMediaWire) – November 15, 2023 – In 2022, fentanyl was responsible for 200 deaths every…
Read More » -
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
[ad_1] FREMONT, CA – (NewMediaWire) – November 15, 2023 – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”): Today, a biotechnology company specializing in…
Read More »